Stock BOLT BIOLIGHT LIFE SCIENCES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials BioLight Life Sciences Ltd.

Equities

BOLT

IL0010952237

Advanced Medical Equipment & Technology

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 10:24:53 2024-05-28 EDT 		5-day change 1st Jan Change
418.2 ILa +1.11% Intraday chart for BioLight Life Sciences Ltd. +2.55% -19.53%
05-05 Alcon Management S.A. entered into an agreement to acquire BELKIN Vision Ltd. form BioLight Life Sciences Ltd. and others for ILS 49.1 million. CI
03-21 BioLight Life Sciences Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 59.51 37.87 34.29 52.62 30.15 24.12
Enterprise Value (EV) 1 16.07 -1.626 -15.89 19.35 13.05 15.57
P/E ratio 0.85 x -3.01 x -2.56 x 144 x -3.85 x -0.93 x
Yield - - - - - -
Capitalization / Revenue 16.1 x 128 x 1,106 x 17,539 x 479 x 204 x
EV / Revenue 4.36 x -5.47 x -512 x 6,449 x 207 x 132 x
EV / EBITDA -0.7 x 0.12 x 1.4 x -1.84 x -1.27 x -1.47 x
EV / FCF -0.52 x -0.19 x 1.75 x -2.89 x -2.35 x -2.13 x
FCF Yield -193% -521% 57.3% -34.6% -42.6% -46.8%
Price to Book 0.72 x 0.55 x 0.58 x 0.87 x 0.57 x 0.81 x
Nbr of stocks (in thousands) 4,543 4,543 4,543 4,560 4,560 4,641
Reference price 2 13.10 8.337 7.549 11.54 6.612 5.197
Announcement Date 19-03-31 20-03-30 21-03-18 22-03-24 23-03-30 24-03-21
1ILS in Million2ILS
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3.687 0.297 0.031 0.003 0.063 0.118
EBITDA 1 -22.93 -13.96 -11.33 -10.53 -10.25 -10.6
EBIT 1 -23.11 -14.02 -11.39 -10.6 -10.32 -10.65
Operating Margin -626.8% -4,719.87% -36,751.61% -353,433.33% -16,384.13% -9,026.27%
Earnings before Tax (EBT) 1 55.14 -15.32 -14.04 -1.911 -8.687 -27.49
Net income 1 65.38 -12.59 -13.38 0.382 -7.847 -26.02
Net margin 1,773.39% -4,239.39% -43,167.74% 12,733.33% -12,455.56% -22,050.85%
EPS 2 15.45 -2.772 -2.946 0.0800 -1.718 -5.603
Free Cash Flow 1 -31.06 8.478 -9.098 -6.703 -5.554 -7.292
FCF margin -842.36% 2,854.59% -29,348.79% -223,433.33% -8,815.08% -6,179.66%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-03-31 20-03-30 21-03-18 22-03-24 23-03-30 24-03-21
1ILS in Million2ILS
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 43.4 39.5 50.2 33.3 17.1 8.55
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -31.1 8.48 -9.1 -6.7 -5.55 -7.29
ROE (net income / shareholders' equity) 120% -20% -22.1% -0.56% -15.1% -65.5%
ROA (Net income/ Total Assets) -25.1% -10.6% -10.2% -10.3% -10.6% -14.7%
Assets 1 -260.4 118.7 131.3 -3.718 73.7 176.8
Book Value Per Share 2 18.10 15.20 13.00 13.30 11.60 6.390
Cash Flow per Share 2 9.480 7.780 6.600 7.340 2.930 1.130
Capex 1 0.05 0.03 2.1 0.63 0.1 1.42
Capex / Sales 1.46% 9.76% 6,770.97% 20,866.67% 155.56% 1,199.15%
Announcement Date 19-03-31 20-03-30 21-03-18 22-03-24 23-03-30 24-03-21
1ILS in Million2ILS
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
BIOLIGHT LIFE SCIENCES LTD. Stock BioLight Life Sciences Ltd.
-19.53% 5.24M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.65% 223B
DANAHER CORPORATION Stock Danaher Corporation
+11.73% 195B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+18.80% 144B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.06% 111B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.32% 65.19B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+14.04% 53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+2.68% 50.28B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+6.46% 44.15B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+1.82% 36.45B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. BOLT Stock
  4. Financials BioLight Life Sciences Ltd.